Intrauterine infection, magnesium sulfate exposure and cerebral palsy in infants born between 26 and 30 weeks of gestation

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 91, Issue 2, 2000, Pages 159-164

  Matsuda, Yoshio ^a   Kouno, Satoshi ^a   Hiroyama, Yoshifumi ^b   Kuraya, Kazue ^a   Kamitomo, Masato ^a   Ibara, Satoshi ^a   Hatae, Masayuki ^a  

^a Kagoshima City Hospital   (Japan)

^b Department of Pediatric Neurology   (Japan)

Author keywords

Cerebral palsy; Gestational age; Intrauterine infection; Magnesium sulfate

Indexed keywords

ANTIBIOTIC AGENT; MAGNESIUM SULFATE; RITODRINE; STEROID;

ACIDOSIS; APGAR SCORE; ARTERIAL PH; ARTICLE; BIRTH WEIGHT; CEREBRAL PALSY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETUS; FETUS ACID BASE BALANCE; FETUS HEART RATE; GESTATIONAL AGE; HUMAN; INTRAUTERINE INFECTION; PLACENTA DISORDER; PREECLAMPSIA; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SOLUTIO PLACENTAE; STATISTICAL MODEL;

EID: 0034123297     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(99)00256-0     Document Type: Article

References (20)

1. Pharoah P., Cooke T., Cooke R.W., Rosenbloom L. Birthweight specific trends in cerebral palsy. Arch Dis Child. 65:1990;602-606.
2. Nelson K.B. Magnesium sulfate and risk of cerebral palsy in very low-birth-weight infants. J Am Med Assoc. 276:1996;1843-1844.
3. Kuban K.C.K., Leviton A., Pagano M., Fenton T., Strassfeld R., Wolff M. Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies. J Clin Neurol. 7:1992;70-76.
4. Murphy D.J., Sellers S., MacKenzie I.Z., Yudkin P.L., Johnson A.M. Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet. 346:1995;1449-1454.
5. Gaffney G., Sellers S., Flavell V., Squier M., Johnson A. Case-control study of intrapartum care, cerebral palsy and perinatal death. Br Med J. 308:1994;743-750.
6. Ikenoue T., Matsuda Y., Kamitomo M., Hokanishi H. Combination therapy of intravenous ritodrine and magnesium sulfate to inhibit preterm labor. Acta Obstet Gynecol Jpn. 41:1989;1972-1978.
7. Iams J.D. Prevention and management of preterm birth. Quilligan E.J., Zuspan F.P. Current therapy in obstetrics and gynecology. 1990;264-268 Saunders, Philadelphia.
8. Zuspan F.P., Ward M.C. Treatment of eclampsia. South Med J. 57:1964;954-961.
9. Parer J.T. Handbook of fetal heart rate monitoring. 1983;85-123 W.B. Saunders, Philadelphia.
10. Newton E.R. Chorioamnionitis and intra-amniotic infection. Clin Obstet Gynecol. 36:1993;795-808.
11. Perkins R.P., Zhou S., Butler C., Skipper B.J. Histologic chorioamnionitis in pregnancies of various gestational ages: Implications in preterm rupture of membranes. Obstet Gynecol. 70:1987;856-861.
12. Dickinson J.E., Eriksen N.L., Meyer B.A., Parisi V.M. The effect of preterm birth on umbilical cord blood gases. Obstet Gynecol. 79:1992;575-578.
13. Spinillo A., Iasci A., Capuzzo E., Egbe T.O., Colonna L., Fazzi E. Two-year infant neurodevelopmental outcome after expectant management and indicated preterm delivery in hypertensive pregnancies. Acta Obstet Gynecol Scand. 73:1994;625-629.
14. Grether J.K., Nelson K.B., Emery E.S., Cummins S.K. Prenatal and perinatal factors and cerebral palsy in very low birth weight infants. J Pediatr. 128:1996;407-414.
15. Prins J.M., Kuijper E.J., Mevissen M.L.C.M., Speelman P., Van Deventer S.J.H. Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum. Infect Immun. 63:1995;2236-2242.
16. Dammann O., Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res. 42:1997;1-8.
17. Shi Y., Li H.Q., Chen C.K., Wang J.H., Pan J., Qin S.W., et al. Association between protective efficacy of antibodies to tumor necrosis factor and suppression of nitric oxide production in neonatal rats with fatal infection. Pediatr Res. 34:1993;345-348.
18. Hirtz D.G., Nelson K. Magnesium sulfate and cerebral palsy in preterm infants. Curr Opin Pediatr. 10:1998;131-137.
19. Schendel D.E., Berg C.J., Yeargin-Allsopp M., Boyle C.A., Decoufle P. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3-5 years. J Am Med Assoc. 276:1996;1805-1810.
20. Matsuda Y., Maeda Y., Ito M., Sakamoto H., Masaoka N., Takada M., et al. Effect of magnesium sulfate treatment on neonatal bone abnormalities. Gynecol Obstet Invest. 44:1997;82-88.